ロード中...
Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina
BACKGROUND: Stroke is the fourth leading cause of death in the United States, and its incidence is especially high in South Carolina. Recombinant tissue plasminogen activator (rtPA) has been given to patients with acute ischemic stroke since 1996 and has shown overall improved outcomes relative to p...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Engage Healthcare Communications, LLC
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031709/ https://ncbi.nlm.nih.gov/pubmed/24991353 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|